Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Oral-Lyn - Oral Insulin for Type 1 and 2 Diabetes



Type 2 diabetes

Type 2 diabetes accounts for the vast majority of cases.

  • Symptoms of diabetes
    There are a range of symptoms that may be suggestive of diabetes, including...
  • Patterns of blood glucose levels
    Typical day-to-day patterns of blood glucose levels in several individuals.
  • Diabetic complications
    Risk factors for diabetic complications.
  • Insulin-dependent diabetes
    Age of onset of type 1 diabetes, formerly known as insulin-dependent diabetes.
  • Diabetes control
    Management of diabetes requires not only good glycaemic control but also...
  • Type 2 diabetes
    Type 2 diabetes accounts for the vast majority of cases.

Back to Project Details



Related Projects

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator
Developed by French pharmaceutical company NicOx, naproxcinod (HCT 3012)...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Lyrica (Pregabalin) - New Gabapentinoid with Wide
Developed by Pfizer, pregabalin, marketed under the brand name Lyrica, is...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.